An Active Pelvis Orthosis (APO) for Post-stroke Gait Rehabilitation: a Pilot Study
APO
Brain Diseases+4
+ Cardiovascular Diseases
+ Central Nervous System Diseases
Treatment Study
Summary
Study start date: March 30, 2023
Actual date on which the first participant was enrolled.The study is focused on helping stroke patients improve their walking speed by using a special device called the Active Pelvis Orthosis (APO). This device is a type of robotic exoskeleton that supports the hips and helps with walking motions. The main goal is to see if this device can safely and effectively increase the natural walking speed of stroke survivors. Understanding whether the APO can enhance walking speed is important because it could provide a new way to support rehabilitation and improve the quality of life for those affected by stroke. Participants in the study will attend multiple sessions where they will practice walking with the APO. The sessions include initial baseline assessments, a few practice sessions to get used to the device, and dedicated training sessions. The effectiveness of the APO will be measured by comparing walking speed before and after the training. Participants' walking abilities will be evaluated using standard walking tests and gait analysis, both with and without the device. This structured approach ensures the study thoroughly assesses the potential benefits and any safety concerns associated with using the APO for rehabilitation.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.20 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Ente Ospedaliero Valduce - UOC di Medicina Riabilitativa Villa Beretta
Lecco, ItalyOpen Ente Ospedaliero Valduce - UOC di Medicina Riabilitativa Villa Beretta in Google Maps